• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Morbidity, Mortality, and Quality Review Committee

    ​​About

    The Morbidity, Mortality, and Quality Review Committee is a multidisciplinary committee established in statute by Health-General-Article §18-107, Annotated Code of Maryland. The committee’s purpose is to prevent and control morbidity and mortality associated with pregnancy, childbirth, infancy, and early childhood and to promote the welfare and hygiene of maternity and infancy.

    Maryland regulation (COMAR 10.11.06.00 - 13) describes the required actions of the Committee. These include that the Committee shall:
    1. Provide consultation to Fetal and Infant Mortality Review (FIMR) teams and other MMQR teams
    2. Conduct confidential and anonymous case reviews of morbidity and mortality associated with pregnancy, childbirth, infancy, and early childhood.
      1. Individual cases or clusters of cases of morbidity or mortality;
      2. Maternal or neonatal transport to or from perinatal centers; and
      3. Aggregate or hospital-specific cases of mortality or morbidity associated with pregnancy, childbirth, infancy, or early childhood.
    3. Undertake annual statistical analysis of the incidence and cause of morbidity and mortality related to pregnancy, childbirth, infancy, and early childhood.
    4. Monitor hospital compliance with the Maryland Perinatal System Standards
    5. Determine factors contributing to morbidity and mortality, and make recommendations for strategies to prevent and reduce morbidity and mortality related to pregnancy, childbirth, infancy, and early childhood throughout the State, including recommendations for changes to law, policy, or practice to prevent and reduce morbidity and mortality and improve the system of care.

    The regulation also describes recommended actions of the Committee, including that the Committee may:
    1. Evaluate the continued effectiveness and efficiency of the Statewide morbidity, mortality, and quality review process associated with pregnancy, childbirth, infancy, and early childhood and make or recommend appropriate changes as necessary;
    2. Establish special panels or ad hoc subcommittees of the Committee as necessary to carry out the duties of the Committee;
    3. Analyze data and review reports or other information from:
      1. FIMR teams;
      2. Other MMQR teams; or
      3. Other entities which are established for the purpose of addressing an aspect of morbidity, mortality, or quality reviews associated with pregnancy, childbirth, infancy, or early childhood.
    4. Develop protocols for data collection regarding morbidity and mortality related to pregnancy, childbirth, infancy, and early childhood;
    5. Examine the policies and procedures of State and local agencies, hospitals, and other entities that participate in the system of care;
    6. Review specific cases regarding pregnancy, childbirth, infancy, or early childhood that the Committee considers necessary to perform its duties; and
    7. Coordinate its activities with other State agencies in order to avoid unnecessary duplication of effort.

    ​​

    ​Meetings​​

    The Morbidity, Mortality, and Quality Review Committee meetings are held Virtually.

    Next Meeting: January 10, 2024
    1:00 pm - 2:30 pm
    Video call Link:  https://meet.google.com/kmf-irwy-odo
    ​Or dial: ‪(US) +1 216-839-0184​
    PIN: ‪532 491 192‬#​​
    Agenda​ : *Coming Soon*​
    ​​​